{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:25:43Z","timestamp":1770643543458,"version":"3.49.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Pre-erythrocytic malaria vaccines hold the promise of inducing sterile protection thereby preventing the morbidity and mortality associated with <jats:italic>Plasmodium<\/jats:italic> infection. The main surface antigen of <jats:italic>P. falciparum<\/jats:italic> sporozoites, i.e., the circumsporozoite protein (CSP), has been extensively explored as a target of such vaccines with significant success in recent years. Systematic adjuvant selection, refinements of the immunization regimen, and physical properties of the antigen may all contribute to the potential of increasing the efficacy of CSP-based vaccines. Protection appears to be dependent in large part on CSP antibodies. However due to a knowledge gap related to the exact correlates of immunity, there is a critical need to improve our ability to down select candidates preclinically before entering clinical trials including with controlled human malaria infections (CHMI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We developed a novel multiplex competition assay based on well-characterized monoclonal antibodies (mAbs) that target crucial epitopes across the CSP molecule. This new tool assesses both, quality and epitope-specific concentrations of vaccine-induced antibodies by measuring their equivalency with a panel of well-characterized, CSP-epitope-specific mAbs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Applying this method to RTS,S-immune sera from a CHMI trial demonstrated a quantitative epitope-specificity profile of antibody responses that can differentiate between protected vs. nonprotected individuals. Aligning vaccine efficacy with quantitation of the epitope fine specificity results of this equivalency assay reveals the importance of epitope specificity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The newly developed serological equivalence assay will inform future vaccine design and possibly even adjuvant selection. This methodology can be adapted to other antigens and disease models, when a panel of relevant mAbs exists, and could offer a unique tool for comparing and down-selecting vaccine formulations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1303446","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T09:50:51Z","timestamp":1702288251000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel antibody competition binding assay identifies distinct serological profiles associated with protection"],"prefix":"10.3389","volume":"14","author":[{"given":"Jessica S.","family":"Bolton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall S.","family":"MacGill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Locke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Regules","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke S.","family":"Bergmann-Leitner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.10.046","article-title":"Updates on immunologic correlates of vaccine-induced protection","volume":"38","author":"Plotkin","year":"2020","journal-title":"Vaccine"},{"key":"B2","unstructured":"KelleherK\n            DrysdaleC\n          World Health OrganizationWho Recommends Groundbreaking Malaria Vaccine for Children at Risk2019"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026330","article-title":"Seasonal malaria vaccination with or without seasonal malaria chemoprevention","volume":"385","author":"Chandramohan","year":"2021","journal-title":"New Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0140-6736(15)60721-8","article-title":"Efficacy and safety of rts,S\/as01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12916-022-02536-5","article-title":"The duration of protection against clinical malaria provided by the combination of seasonal rts,S\/as01(E) vaccination and seasonal malaria chemoprevention versus either intervention given alone","volume":"20","author":"Cairns","year":"2022","journal-title":"BMC Med"},{"key":"B6","volume-title":"World malaria report, 2022","year":"2022"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant matrix-M, with seasonal administration to children in Burkina Faso: A randomised controlled trial","volume":"397","author":"Datoo","year":"2021","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12936-016-1348-9","article-title":"The biological function of antibodies induced by the rts,S\/as01 malaria vaccine candidate is determined by their fine specificity","volume":"15","author":"Chaudhury","year":"2016","journal-title":"Malar J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7998","DOI":"10.1038\/s41598-017-08526-5","article-title":"Delayed fractional dose regimen of the rts,S\/as01 malaria vaccine candidate enhances an igg4 response that inhibits serum opsonophagocytosis","volume":"7","author":"Chaudhury","year":"2017","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw237","article-title":"Fractional third and fourth dose of rts,S\/as01 malaria candidate vaccine: A phase 2a controlled human malaria parasite infection and immunogenicity study","volume":"214","author":"Regules","year":"2016","journal-title":"J Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fdata.2021.672460","article-title":"Comprehensive data integration approach to assess immune responses and correlates of rts,S\/as01-mediated protection from malaria infection in controlled human malaria infection trials","volume":"4","author":"Young","year":"2021","journal-title":"Front Big Data"},{"key":"B12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12936-020-03225-5","article-title":"Comparison of elisa with electro-chemiluminescence technology for the qualitative and quantitative assessment of serological responses to vaccination","volume":"19","author":"Bolton","year":"2020","journal-title":"Malar J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2021.101345","article-title":"Multiplex serological assay for establishing serological profiles of polymorphic, closely related peptide antigens","volume":"8","author":"Bolton","year":"2021","journal-title":"MethodsX"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/jcm11071839","article-title":"Assessing Prevalence and Transmission Rates of Malaria through Simultaneous Profiling of Antibody Responses against Plasmodium and Anopheles Antigens","volume":"11","author":"Chaudhury","year":"2022","journal-title":"J Clin Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.12.055","article-title":"Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the rts,S malaria vaccine","volume":"39","author":"Chaudhury","year":"2021","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010409","article-title":"A novel CSP C-terminal epitope targeted by an antibody with protective activity against plasmodium falciparum","volume":"18","author":"Beutler","year":"2022","journal-title":"PloS Pathog"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200061","article-title":"A high-affinity antibody against the csp N-terminal domain lacks plasmodium falciparum inhibitory activity","volume":"217","author":"Thai","year":"2020","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010133","article-title":"Protective effects of combining monoclonal antibodies and vaccines against the plasmodium falciparum circumsporozoite protein","volume":"17","author":"Wang","year":"2021","journal-title":"PloS Pathog"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2019.12.029","article-title":"Diverse antibody responses to conserved structural motifs in plasmodium falciparum circumsporozoite protein","volume":"432","author":"Pholcharee","year":"2020","journal-title":"J Mol Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010042","article-title":"The P. Falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo","volume":"17","author":"Flores-Garcia","year":"2021","journal-title":"PloS Pathog"},{"key":"B21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.immuni.2020.08.014","article-title":"A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver","volume":"53","author":"Wang","year":"2020","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41467-021-21221-4","article-title":"Structural and biophysical correlation of anti-nanp antibodies with in vivo protection against P. Falciparum","volume":"12","author":"Pholcharee","year":"2021","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1715812114","article-title":"Structural basis for antibody recognition of the nanp repeats in plasmodium falciparum circumsporozoite protein","volume":"114","author":"Oyen","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2022.09.20.508747","DOI":"10.1101\/2022.09.20.508747","article-title":"Affinity-matured homotypic interactions induce spectrum of pfcsp-antibody structures that influence protection from malaria infection","author":"Martin","year":"2022","journal-title":"bioRxiv"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101488","article-title":"The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host","volume":"208","author":"Coppi","year":"2011","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032524","article-title":"Roles of the amino terminal region and repeat region of the plasmodium berghei circumsporozoite protein in parasite infectivity","volume":"7","author":"Aldrich","year":"2012","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034031","article-title":"A monoclonal antibody for malaria prevention","volume":"385","author":"Gaudinski","year":"2021","journal-title":"New Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJMoa2203067","article-title":"Low-dose subcutaneous or intravenous monoclonal antibody to prevent malaria","volume":"387","author":"Wu","year":"2022","journal-title":"New Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau8529","article-title":"Cryo-em structure of P. Falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-fab contacts","volume":"4","author":"Oyen","year":"2018","journal-title":"Sci Adv"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41467-021-21221-4","article-title":"Structural and biophysical correlation of anti-nanp antibodies with in vivo protection against P","volume":"12","author":"Pholcharee","year":"2021","journal-title":"Falciparum. Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0881-9","article-title":"Evolution of protective human antibodies against plasmodium falciparum circumsporozoite protein repeat motifs","volume":"26","author":"Murugan","year":"2020","journal-title":"Nat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar5304","article-title":"Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope","volume":"360","author":"Imkeller","year":"2018","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4512","article-title":"A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite","volume":"24","author":"Kisalu","year":"2018","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the rts,S\/as01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"New Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.20170869","article-title":"Rare pfcsp C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection","volume":"215","author":"Scally","year":"2018","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12916-018-1186-4","article-title":"Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following rts,S\/as01e vaccination in African children","volume":"16","author":"Ubillos","year":"2018","journal-title":"BMC Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1038\/s41467-019-10195-z","article-title":"Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with rts,S\/as01e malaria vaccine efficacy","volume":"10","author":"Dobano","year":"2019","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa644","article-title":"Magnitude, specificity, and avidity of sporozoite-specific antibodies associate with protection status and distinguish among rts,S\/as01 dose regimens","volume":"8","author":"Dennison","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb4757","article-title":"Mapping functional humoral correlates of protection against malaria challenge following rts,S\/as01 vaccination","volume":"12","author":"Suscovich","year":"2020","journal-title":"Sci Transl Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1669415","article-title":"Rts,S\/as01 vaccine (Mosquirix): an overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/srep46621","article-title":"Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine","volume":"7","author":"Collins","year":"2017","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of falciparum malaria vaccines rts,S\/as01b and rts,S\/as02a in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"Kester","year":"2009","journal-title":"J Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12936-016-1596-8","article-title":"A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of plasmodium falciparum","volume":"15","author":"Radin","year":"2016","journal-title":"Malaria J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061395","article-title":"The relationship between rts,S vaccine-induced antibodies, cd4(+) T cell responses and protection against plasmodium falciparum infection","volume":"8","author":"White","year":"2013","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111020","article-title":"Igg2 Antibodies against a Clinical Grade Plasmodium Falciparum CSP Vaccine Antigen Associate with Protection against Transgenic Sporozoite Challenge in Mice","volume":"9","author":"Schwenk","year":"2014","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.immuni.2017.11.007","article-title":"Natural parasite exposure induces protective human anti-malarial antibodies","volume":"47","author":"Triller","year":"2017","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81401","article-title":"Antibodies to repeat-containing antigens in plasmodium falciparum are exposure-dependent and short-lived in children in natural malaria infections","volume":"12","author":"Raghavan","year":"2023","journal-title":"eLife"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1303446\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T09:50:54Z","timestamp":1702288254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1303446\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2023.1303446"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1303446","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"article-number":"1303446"}}